We have also demonstrated that the novel USP7 inhibitor Almac4 is effective against NB tumor growth in TP53 wild-type NB cells regardless of MYCN status through induction of caspase-mediated apoptosis, but Almac4 was less effective in TP53-mutated or TP53-null NB cells. The gene discussed is MYCN; the disease is neoplasm.